Optical Power:25 Watts
Fiber Connector:SMA 905
Cooling:Pelier Module and Air
Laser Safety Class:4
Supply Voltage:110 – 240 VAC
Frequency Sector:50 – 60 Hz
* Lipotherme is a safe, effective, minimally invasive procedure that uses a laser to liquefy and remove unwanted fat in targeted body zones. In addition to removing unwanted fat, Lipotherme’s thermal effect causes the skin to contract, resulting in firmer, smoother skin that further enhances your body shaping goals.
* The Lipotherme continuous wave diode laser operates with a unique 980 nm source filter that emits from one to 25 watts of power in a continuous wave, unlike the Nd:YAG lasers, which emit pulsed waves.
* The power is variable so that physicians can customize the treatment for each patient and body area. For example, 6 W may be appropriate for the chin, arms, and knees, while 15 W may be appropriate for the thighs, hips, and buttocks.
*Does the LSO Medical/Osyris charge the new owner a ONE TIME equipment RECERTIFICATION FEE for the purchase of consumables and service? Unknown
*Can Service and Consumables be purchased from an OUTSIDE SOURCE without a recertification fee? Yes
*Service and consumables can be obtained by Innovative BioMedical Resources 800-518-7611, www.innovativebiomedicalresources.com
*Information updated 09/2013
Exotherme is a transcutaneous vascular laser, dedicated to spider veins and telangiectasias, up to 2mm of diameter, for a safe, efficient and painless treatment.
The principle of the Exotherme laser is based on the thermal action of the laser. The transcutaneous irradiation (with a penetration of 1 to 2 mm in the tissue) causes tissue selective absorption by hemeglobin (hemoglobin is the main target of the laser).
The effect of selective photocoagulation is based on two effects:
Conversion of light energy into heat,
Coagulation of the vascular wall with collagen denaturation.
Selective photocoagulation does not cause purpura (contrary to photothermolysis).
The superficial vessels, from 0.2 to 2 mm of diameter.
Exotherme is cleared on the US market for the photocoaguation of leg telangiecatasias.